Committee Advice Documents - Safety Assessments
On this page
Skip the menu of subheadings on this page.Genetically modified GHB811 cotton - RP1232
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Genetically modified GHB811 cotton
Genetically modified GMB151 soybean - RP1123
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Genetically modified GMB151 soybean
Genetically modified DP4114xMON810xMIR604xNK603 Maize and sub-combinations - RP1506
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Genetically modified DP4114xMON810xMIR604xNK603 Maize and sub-combinations
Genetically modified 73496 oilseed rape - RP1372
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Genetically modified 73496 oil seedrape
Calcidiol (25-hydroxycholecalciferol monohydrate) - RP35
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Calcidiol (25-hydroxycholecalciferol monohydrate) RP35
Synthetic cannabidiol (CBD) - RP07
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Synthetic cannabidiol (CBD) RP07
Cannabidiol (CBD) isolate - RP350
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Cannabidiol (CBD) isolate - RP350
Schizochytrium sp.oil rich in DHA and EPA - RP1411
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Schizochytrium sp. oil rich in DHA and EPA - RP1411
Magnesium L-threonate - RP956
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Magnesium L-threonate as a novel food for use in food supplements - RP956
Barley Rice Protein - RP19
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Cetylated Fatty Acids - RP200
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
3-fucosyllactose (3-FL) - RP1202
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
3-fucosyllactose (3-FL) - RP1202
Lacto-N-fucopentaose I (LNFP-I) and 2'-fucosyllactose (2'-FL) - RP549
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Lacto-N-fucopentaose I (LNFP-l) and 2'-fucosyllactose (2'-FL) - RP549